Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The most common malignant tumor of the thyroid is papillary carcinoma. Sarcoma of the thyroid is encountered very rarely; its therapy is complex and poses significant problems due to the problematic location of the tumor. A 14-year-old female was diagnosed with undifferentiated sarcoma of the thyroid and received combined therapy comprising surgery, chemo- and radiotherapy without significant side effects. This case underlines the fact that undifferentiated thyroid sarcoma may be a diagnostic possibility in children with malignant masses of the neck and may be successfully treated with modern therapeutic strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.22435 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A case report of thyroid myofibroblastic sarcoma.
Medicine (Baltimore)
August 2025
Liangzhou Hospital, Wuwei, China.
Rationale: High-grade myofibroblastic sarcoma (HGMS) is a rare mesenchymal tumor with a high recurrence and metastatic rate. Few cases of high-grade myofibroblastic sarcomas have been reported. Herein, we report the first case of HGMS originating from the thyroid.
View Article and Find Full Text PDFSintilimab plus anlotinib in patients with pre-treated locally advanced or metastatic sarcoma: a prospective, single-arm, phase II clinical trial.
Cancer Immunol Res
August 2025
Shandong Cancer Hospital and Institute. Shandong First Medical University and Shandong Academy of Medical Sciences., Jinan, Shandong, China.
Advanced sarcomas have limited treatment options after standard therapy, and therefore we investigated the efficacy and safety of sintilimab plus anlotinib in this setting. Patients aged 18-75 years with advanced sarcomas and prior systemic therapy were enrolled. Patients with untreated, primary chemotherapy-resistant tumor types, such as alveolar soft part sarcoma, clear cell sarcoma, etc.
View Article and Find Full Text PDFAnaplastic Sarcoma of the Kidney in a Child with Syndrome: A Case Report.
Surg Case Rep
August 2025
Department of Pediatric Surgery, Nihon University School of Medicine, Tokyo, Japan.
Introduction: Anaplastic sarcoma of the kidney (ASK) is a rare renal tumor, with fewer than 50 cases reported in the literature since 2007. ASK is pathologically characterized by the presence of cystic and solid areas consisting of spindle cells showing marked anaplasia. Recent studies have reported that the vast majority of patients with ASK have variants, and that these tumors are part of the syndrome, a hereditary cancer predisposition disorder.
View Article and Find Full Text PDFPediatric and Young Adult Cancer Incidence in the United States During the COVID-19 Pandemic.
Pediatr Blood Cancer
August 2025
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: Cancer incidence decreased during the COVID-19 pandemic; this study describes cancer incidence changes for children, adolescents, and young adults during this period. We used US Cancer Statistics (USCS) to describe potential impacts of the pandemic on cancer incidence for persons 0-39 years.
Methods: We used data from USCS, covering 98% of the US population, to evaluate cancer case counts, incidence rates, and monthly counts; incidence rate ratios were calculated comparing year 2019 (baseline) to 2020 and 2021.
Secondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma.
Genes Chromosomes Cancer
August 2025
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm of uncertain histogenesis, characterized by recurrent gene fusions involving NR4A3 with various gene partners (EWSR1, TAF15, FUS, etc.). Although the impact of fusion variants has been linked to histology and prognosis, no study to date has comprehensively investigated the incidence and spectrum of secondary genetic alterations (SGAs) in EMC with regard to their association with fusion type and clinical impact.
View Article and Find Full Text PDF